data_1u2f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u2f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.545 -0.539 . . . . 4.3499999999999996 109.545 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER 65.22 9.74 5.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.868 . . . . 4.75 109.717 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -102.68 131.66 49.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 2.6499999999999999 109.253 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' A' ' 64' ' ' ALA . 27.6 mt -117.98 157.23 27.14 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.158 -0.964 . . . . 1.8200000000000001 109.887 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 3.4 t80 -108.45 147.38 31.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.832 . . . . 2.29 109.442 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 2.5 t -126.03 153.03 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 1.05 108.835 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' LYS . . . -135.37 170.21 23.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.25 109.562 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 6.1 m-80 62.5 25.63 15.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.375 -1.074 . . . . 1.1599999999999999 108.343 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.529 HD13 ' N ' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -98.31 141.88 23.67 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.275 -0.639 . . . . 1.0700000000000001 109.275 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.97 88.6 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.581 2.187 . . . . 0.32000000000000001 110.45 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.635 ' CG ' ' N ' ' A' ' 12' ' ' GLY . 9.0 t80 -48.13 167.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.12 -0.988 . . . . 2.1899999999999999 109.246 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' N ' ' CG ' ' A' ' 11' ' ' PHE . . . 101.77 -48.17 1.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.345 -1.902 . . . . 0.47999999999999998 108.345 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.556 ' CD1' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -47.79 155.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.543 -0.975 . . . . 1.1200000000000001 108.793 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' O ' ' CD1' ' A' ' 13' ' ' ILE . 57.8 p -82.31 -169.1 2.25 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.918 -1.114 . . . . 1.1599999999999999 110.845 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 18.8 tt0 -90.31 4.87 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.642 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.06 -57.87 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 1.77 109.674 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -44.84 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 1.0800000000000001 109.706 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.559 ' HG2' ' CZ ' ' A' ' 72' ' ' PHE . 11.0 mmm -43.56 -56.69 3.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 1.4199999999999999 109.6 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.507 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 55.5 ttm -43.73 -69.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.875 . . . . 1.3899999999999999 109.661 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 14.2 t70 -62.83 -10.42 13.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.484 -0.76 . . . . 1.1100000000000001 110.197 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 71' ' ' ILE . 25.9 t80 -82.31 -29.85 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.003 . . . . 2.1699999999999999 109.861 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 53' ' ' LEU . 10.6 m-85 -90.85 -41.28 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 2.1299999999999999 110.857 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 19' ' ' MET . 8.1 p30 -76.62 -40.94 47.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.864 -1.147 . . . . 0.26000000000000001 109.425 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 20' ' ' ASP . . . -47.14 -26.07 1.04 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.446 -0.946 . . . . 1.1299999999999999 108.446 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' O ' HD11 ' A' ' 28' ' ' LEU . 85.4 mm-40 -86.66 -32.53 20.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.495 -0.928 . . . . 1.4399999999999999 108.495 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.475 ' N ' ' O ' ' A' ' 23' ' ' ASN . 2.8 mtt -72.71 -24.62 61.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.525 -0.735 . . . . 2.6499999999999999 109.032 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 28' ' ' LEU . 33.7 mmm-85 -79.99 -13.29 59.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 3.8700000000000001 109.657 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -44.72 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 2.0299999999999998 109.598 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.95 -21.85 46.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.641 -1.384 . . . . 1.47 109.641 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.42 59.56 0.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 1.6899999999999999 109.498 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.406 ' O ' HG21 ' A' ' 32' ' ' THR . 37.2 mt -81.42 -9.72 59.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.16 . . . . 2.0499999999999998 109.541 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 31' ' ' LEU . 31.9 p -140.09 131.76 27.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.4199999999999999 109.607 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.54 64.23 1.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 5.3700000000000001 109.231 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' CB ' ' HD2' ' A' ' 35' ' ' PRO . . . -132.34 177.33 2.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 3.98 109.276 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 34' ' ' ALA . 35.0 Cg_endo -77.6 56.11 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.547 2.165 . . . . 5.0199999999999996 110.307 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 -161.06 33.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.399 -1.48 . . . . 2.5299999999999998 109.399 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -122.28 172.6 5.0 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 2.8100000000000001 109.376 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 34.0 Cg_endo -77.65 -73.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.666 2.244 . . . . 0.72999999999999998 110.499 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.606 ' CG1' ' CG2' ' A' ' 42' ' ' VAL . 56.7 t -50.23 148.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.038 -1.039 . . . . 1.0700000000000001 108.766 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' N ' HG11 ' A' ' 39' ' ' VAL . 17.4 tp -126.86 -38.48 2.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 2.3500000000000001 111.226 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' CB ' ' OE1' ' A' ' 54' ' ' GLU . . . -136.77 104.69 5.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.75 -1.219 . . . . 1.22 110.692 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.606 ' CG2' ' CG1' ' A' ' 39' ' ' VAL . 40.8 t -119.83 72.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 1.6499999999999999 109.47 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.425 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 16.3 mt-30 -71.57 157.23 38.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 2.73 109.557 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 44' ' ' ILE . 5.3 mp -105.73 168.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 1.24 109.178 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -129.07 144.35 51.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 3.3100000000000001 109.755 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.583 ' HG3' ' CE1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -88.47 -149.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 5.4000000000000004 109.434 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 76.8 m-20 61.6 -125.64 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 5.0599999999999996 109.266 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -52.32 -19.72 2.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.802 -1.186 . . . . 6.3799999999999999 109.508 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 11.6 m-20 80.62 97.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.462 -0.774 . . . . 4.2999999999999998 109.575 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CE2' ' CB ' ' A' ' 45' ' ' ASN . 1.2 p90 -153.37 168.89 24.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.805 -0.813 . . . . 2.46 108.805 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.25 167.77 21.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.975 -1.078 . . . . 1.04 110.782 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 5' ' ' TYR . 5.9 m-85 -134.36 149.69 50.85 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.201 -1.037 . . . . 2.2400000000000002 108.201 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.638 ' CD1' ' CE2' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -123.21 116.23 23.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.944 -1.097 . . . . 1.4299999999999999 108.764 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' OE1' ' CB ' ' A' ' 41' ' ' ALA . 62.5 tt0 -95.98 121.97 38.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.504 -0.747 . . . . 2.3900000000000001 110.34 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.591 ' CD1' HG21 ' A' ' 39' ' ' VAL . 2.0 m-85 -107.9 121.19 44.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 2.1400000000000001 109.254 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -1.0 57.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.387 -0.821 . . . . 4.3300000000000001 109.426 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -161.0 -35.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 2.1000000000000001 110.554 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.55 ' CG1' ' HB3' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -42.95 124.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.099 -1.001 . . . . 1.8600000000000001 109.875 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.51 43.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 3.0499999999999998 108.743 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 5.1 tt0 -123.37 1.13 9.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.48 -0.763 . . . . 3.6000000000000001 109.502 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 60' ' ' GLU . 2.4 t -43.16 -25.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 1.5700000000000001 109.911 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 63' ' ' GLN . 4.5 t -86.65 -43.52 12.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 1.21 110.101 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' N ' ' CG2' ' A' ' 62' ' ' THR . 21.8 mt-30 -86.28 -16.42 37.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 2.1499999999999999 109.765 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 4' ' ' LEU . . . -48.96 -30.86 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.03 -1.044 . . . . 1.21 108.701 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.429 ' HE2' ' HG3' ' A' ' 81' ' ' ARG . 78.2 mtp -57.41 -19.39 23.19 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.23 -1.026 . . . . 2.6699999999999999 108.23 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 63' ' ' GLN . . . -57.15 -32.37 66.31 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.636 -0.665 . . . . 1.0900000000000001 109.246 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' A' ' 68' ' ' ASP . 31.4 m-85 -81.0 4.01 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 2.23 108.873 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HA ' HG13 ' A' ' 79' ' ' ILE . 13.5 t0 -39.82 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.557 -0.714 . . . . 1.1200000000000001 109.453 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' HG21 ' A' ' 70' ' ' ILE . . . 102.86 -73.15 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.89 -1.684 . . . . 0.20999999999999999 108.89 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.568 HG21 ' N ' ' A' ' 71' ' ' ILE . 7.2 tt 39.18 -132.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.826 -0.808 . . . . 1.05 109.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.568 ' N ' HG21 ' A' ' 70' ' ' ILE . 12.1 mm -152.29 115.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.015 -1.678 . . . . 1.1299999999999999 109.662 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.559 ' CZ ' ' HG2' ' A' ' 18' ' ' MET . 42.3 t80 -122.93 129.66 51.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.336 -0.853 . . . . 2.1600000000000001 109.588 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 45.35 39.13 4.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 1.29 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.33 60.79 8.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.439 -1.464 . . . . 0.44 109.439 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.425 ' O ' HD22 ' A' ' 77' ' ' LEU . 3.4 tp-100 -168.84 127.89 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 1.8400000000000001 109.562 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -51.16 160.99 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 1.0 109.747 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' CD1' HG21 ' A' ' 70' ' ' ILE . 14.9 mt -129.86 -171.83 2.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 1.05 109.482 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -160.14 95.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.96 . . . . 2.3999999999999999 109.561 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' A' ' 68' ' ' ASP . 1.3 mt -79.74 149.54 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 1.49 109.56 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -130.02 -177.6 4.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 2.8599999999999999 109.682 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.429 ' HG3' ' HE2' ' A' ' 65' ' ' MET . 7.8 mtm180 -117.51 95.29 47.35 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 4.6799999999999997 109.34 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 35.4 Cg_endo -77.23 49.91 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.619 2.213 . . . . 1.5900000000000001 110.52 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 84' ' ' ASP . 7.1 t60 -129.86 -32.91 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 5.9100000000000001 109.665 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER 40.66 56.0 2.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.463 -0.773 . . . . 5.5499999999999998 109.708 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -78.55 159.63 28.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 8.6799999999999997 109.576 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' OE1' ' CE2' ' A' ' 85' ' ' TYR . 93.0 mt-30 45.49 91.48 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 7.3099999999999996 109.511 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 35.3 Cg_endo -77.67 94.28 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.825 2.35 . . . . 5.5700000000000003 110.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -42.35 102.57 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 7.7400000000000002 109.656 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 36.1 Cg_endo -78.47 171.49 16.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.496 2.131 . . . . 7.9400000000000004 110.382 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 118.008 -1.44 . . . . 9.3000000000000007 109.556 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.545 -0.539 . . . . 3.8599999999999999 109.545 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER 65.22 9.74 5.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.868 . . . . 4.1200000000000001 109.717 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -102.68 131.66 49.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 2.1099999999999999 109.253 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.87 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 27.6 mt -117.98 157.23 27.14 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.158 -0.964 . . . . 1.2 109.887 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 3.4 t80 -108.45 147.38 31.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.832 . . . . 1.3700000000000001 109.442 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 2.5 t -126.03 153.03 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 0.22 108.835 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' LYS . . . -135.37 170.21 23.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.20000000000000001 109.562 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . 8.7 m120 62.5 25.63 15.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.375 -1.074 . . . . 0.72999999999999998 108.343 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.742 ' C ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -98.31 141.88 23.67 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.275 -0.639 . . . . 0.28999999999999998 109.275 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' N ' HD12 ' A' ' 9' ' ' ILE . 36.0 Cg_endo -78.97 88.6 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.581 2.187 . . . . 0.28000000000000003 110.45 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.635 ' CG ' ' N ' ' A' ' 12' ' ' GLY . 9.0 t80 -48.13 167.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.12 -0.988 . . . . 1.3400000000000001 109.246 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' N ' ' CG ' ' A' ' 11' ' ' PHE . . . 101.77 -48.17 1.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.345 -1.902 . . . . 0.45000000000000001 108.345 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -47.79 155.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.543 -0.975 . . . . 0.34000000000000002 108.793 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 13' ' ' ILE . 57.8 p -82.31 -169.1 2.25 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.918 -1.114 . . . . 0.44 110.845 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' MET . 18.8 tt0 -90.31 4.87 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.642 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.06 -57.87 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 1.77 109.674 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB3' HD11 ' A' ' 13' ' ' ILE . . . -44.84 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.31 109.706 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 72' ' ' PHE . 11.0 mmm -43.56 -56.69 3.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 1.1100000000000001 109.6 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.507 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 55.5 ttm -43.73 -69.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.875 . . . . 0.76000000000000001 109.661 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 t70 -62.83 -10.42 13.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.484 -0.76 . . . . 1.1100000000000001 110.197 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 71' ' ' ILE . 25.9 t80 -82.31 -29.85 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.003 . . . . 1.26 109.861 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CG ' HD22 ' A' ' 53' ' ' LEU . 10.6 m-85 -90.85 -41.28 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 1.25 110.857 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 20' ' ' ASP . 8.1 p30 -76.62 -40.94 47.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.864 -1.147 . . . . 0.26000000000000001 109.425 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -47.14 -26.07 1.04 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.446 -0.946 . . . . 0.35999999999999999 108.446 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' HA ' HD12 ' A' ' 28' ' ' LEU . 85.4 mm-40 -86.66 -32.53 20.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.495 -0.928 . . . . 1.4399999999999999 108.495 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 58' ' ' VAL . 2.8 mtt -72.71 -24.62 61.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.525 -0.735 . . . . 2.1499999999999999 109.032 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 28' ' ' LEU . 33.7 mmm-85 -79.99 -13.29 59.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 3.2599999999999998 109.657 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -44.72 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 1.51 109.598 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.95 -21.85 46.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.641 -1.384 . . . . 1.4099999999999999 109.641 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.42 59.56 0.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 1.55 109.498 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.2 mt -81.42 -9.72 59.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.16 . . . . 1.76 109.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 38' ' ' PRO . 31.9 p -140.09 131.76 27.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.4199999999999999 109.607 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.54 64.23 1.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 4.8499999999999996 109.231 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.992 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -132.34 177.33 2.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 3.52 109.276 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.992 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 35.0 Cg_endo -77.6 56.11 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.547 2.165 . . . . 4.25 110.307 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 -161.06 33.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.399 -1.48 . . . . 2.3100000000000001 109.399 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -122.28 172.6 5.0 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 2.4399999999999999 109.376 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 34.0 Cg_endo -77.65 -73.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.666 2.244 . . . . 0.65000000000000002 110.499 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.913 HG22 ' CD1' ' A' ' 55' ' ' PHE . 56.7 t -50.23 148.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.038 -1.039 . . . . 0.35999999999999999 108.766 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -126.86 -38.48 2.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 1.78 111.226 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . . . -136.77 104.69 5.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.75 -1.219 . . . . 0.57999999999999996 110.692 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 53' ' ' LEU . 40.8 t -119.83 72.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 1.01 109.47 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.444 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 16.3 mt-30 -71.57 157.23 38.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 2.29 109.557 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 45' ' ' ASN . 5.3 mp -105.73 168.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 109.178 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -129.07 144.35 51.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 2.79 109.755 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -88.47 -149.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 4.7300000000000004 109.434 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 76.8 m-20 61.6 -125.64 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 5.0599999999999996 109.266 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -52.32 -19.72 2.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.802 -1.186 . . . . 6.1200000000000001 109.508 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 11.6 m-20 80.62 97.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.462 -0.774 . . . . 3.6800000000000002 109.575 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CE2' ' CB ' ' A' ' 45' ' ' ASN . 1.2 p90 -153.37 168.89 24.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.805 -0.813 . . . . 1.6399999999999999 108.805 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.25 167.77 21.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.975 -1.078 . . . . 0.28000000000000003 110.782 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.81 ' O ' HG13 ' A' ' 42' ' ' VAL . 5.9 m-85 -134.36 149.69 50.85 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.201 -1.037 . . . . 1.3200000000000001 108.201 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.83 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -123.21 116.23 23.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.944 -1.097 . . . . 0.73999999999999999 108.764 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 62.5 tt0 -95.98 121.97 38.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.504 -0.747 . . . . 2.3900000000000001 110.34 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 39' ' ' VAL . 2.0 m-85 -107.9 121.19 44.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 1.24 109.254 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -1.0 57.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.387 -0.821 . . . . 3.71 109.426 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -161.0 -35.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 1.6899999999999999 110.554 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -42.95 124.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.099 -1.001 . . . . 1.6899999999999999 109.875 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.51 43.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 3.0499999999999998 108.743 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 5.1 tt0 -123.37 1.13 9.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.48 -0.763 . . . . 3.6000000000000001 109.502 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 60' ' ' GLU . 2.4 t -43.16 -25.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.97999999999999998 109.911 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.534 ' CG2' ' HG3' ' A' ' 63' ' ' GLN . 4.5 t -86.65 -43.52 12.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.71999999999999997 110.101 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 21.8 mt-30 -86.28 -16.42 37.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 1.49 109.765 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.87 ' HB3' ' CD1' ' A' ' 4' ' ' LEU . . . -48.96 -30.86 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.03 -1.044 . . . . 0.52000000000000002 108.701 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.41 -19.39 23.19 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.23 -1.026 . . . . 2.1299999999999999 108.23 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.15 -32.37 66.31 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.636 -0.665 . . . . 0.33000000000000002 109.246 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' A' ' 68' ' ' ASP . 31.4 m-85 -81.0 4.01 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 1.3200000000000001 108.873 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 79' ' ' ILE . 13.5 t0 -39.82 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.557 -0.714 . . . . 1.1200000000000001 109.453 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 77' ' ' LEU . . . 102.86 -73.15 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.89 -1.684 . . . . 0.19 108.89 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.865 HG22 HD12 ' A' ' 77' ' ' LEU . 7.2 tt 39.18 -132.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.826 -0.808 . . . . 0.26000000000000001 109.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.697 ' N ' HG23 ' A' ' 70' ' ' ILE . 12.1 mm -152.29 115.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.015 -1.678 . . . . 0.29999999999999999 109.662 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.897 ' HB3' HD21 ' A' ' 77' ' ' LEU . 42.3 t80 -122.93 129.66 51.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.336 -0.853 . . . . 1.25 109.588 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 45.35 39.13 4.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 1.29 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.33 60.79 8.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.439 -1.464 . . . . 0.42999999999999999 109.439 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -168.84 127.89 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 1.6100000000000001 109.562 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.482 ' O ' HD23 ' A' ' 77' ' ' LEU . 4.4 t -51.16 160.99 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.32000000000000001 109.747 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 72' ' ' PHE . 14.9 mt -129.86 -171.83 2.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.25 109.482 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -160.14 95.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.96 . . . . 1.8799999999999999 109.561 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' A' ' 22' ' ' PHE . 1.3 mt -79.74 149.54 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.81000000000000005 109.56 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -130.02 -177.6 4.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 2.4300000000000002 109.682 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -117.51 95.29 47.35 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 4.0700000000000003 109.34 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 35.4 Cg_endo -77.23 49.91 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.619 2.213 . . . . 1.5900000000000001 110.52 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 84' ' ' ASP . 58.4 t-80 -129.86 -32.91 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 5.0599999999999996 109.665 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER 40.66 56.0 2.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.463 -0.773 . . . . 5.5499999999999998 109.708 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -78.55 159.63 28.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 8.4299999999999997 109.576 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' OE1' ' CE2' ' A' ' 85' ' ' TYR . 93.0 mt-30 45.49 91.48 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 6.6500000000000004 109.511 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 35.3 Cg_endo -77.67 94.28 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.825 2.35 . . . . 5.0899999999999999 110.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -42.35 102.57 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 7.3899999999999997 109.656 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 36.1 Cg_endo -78.47 171.49 16.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.496 2.131 . . . . 7.6100000000000003 110.382 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 118.008 -1.44 . . . . 9.3000000000000007 109.556 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.545 -0.539 . . . . 3.8599999999999999 109.545 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER 65.22 9.74 5.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.868 . . . . 4.1200000000000001 109.717 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -102.68 131.66 49.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 2.1099999999999999 109.253 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.87 ' CD1' ' HB3' ' A' ' 64' ' ' ALA . 27.6 mt -117.98 157.23 27.14 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.158 -0.964 . . . . 1.2 109.887 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.568 ' HB2' ' CE1' ' A' ' 52' ' ' PHE . 3.4 t80 -108.45 147.38 31.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.832 . . . . 1.3700000000000001 109.442 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ILE . 2.5 t -126.03 153.03 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -0.874 . . . . 0.22 108.835 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 78' ' ' LYS . . . -135.37 170.21 23.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.562 -1.415 . . . . 0.20000000000000001 109.562 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.498 ' HB2' ' HA ' ' A' ' 77' ' ' LEU . 6.1 m-80 62.5 25.63 15.26 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.375 -1.074 . . . . 0.72999999999999998 108.343 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.742 ' C ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -98.31 141.88 23.67 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.275 -0.639 . . . . 0.28999999999999998 109.275 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' N ' HD12 ' A' ' 9' ' ' ILE . 36.0 Cg_endo -78.97 88.6 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.581 2.187 . . . . 0.28000000000000003 110.45 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.635 ' CG ' ' N ' ' A' ' 12' ' ' GLY . 9.0 t80 -48.13 167.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.12 -0.988 . . . . 1.3400000000000001 109.246 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' N ' ' CG ' ' A' ' 11' ' ' PHE . . . 101.77 -48.17 1.12 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.345 -1.902 . . . . 0.45000000000000001 108.345 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -47.79 155.64 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.543 -0.975 . . . . 0.34000000000000002 108.793 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.871 ' O ' HD13 ' A' ' 13' ' ' ILE . 57.8 p -82.31 -169.1 2.25 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.918 -1.114 . . . . 0.44 110.845 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 19' ' ' MET . 18.8 tt0 -90.31 4.87 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.959 -1.088 . . . . 1.3 109.642 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.06 -57.87 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 1.77 109.674 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.848 ' HB3' HD11 ' A' ' 13' ' ' ILE . . . -44.84 -75.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.31 109.706 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 72' ' ' PHE . 11.0 mmm -43.56 -56.69 3.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.233 -0.917 . . . . 1.1100000000000001 109.6 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.507 ' O ' ' ND2' ' A' ' 23' ' ' ASN . 55.5 ttm -43.73 -69.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.875 . . . . 0.76000000000000001 109.661 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.2 t70 -62.83 -10.42 13.1 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.484 -0.76 . . . . 1.1100000000000001 110.197 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' CZ ' ' O ' ' A' ' 71' ' ' ILE . 25.9 t80 -82.31 -29.85 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.003 . . . . 1.26 109.861 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CG ' HD22 ' A' ' 53' ' ' LEU . 10.6 m-85 -90.85 -41.28 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.081 -1.012 . . . . 1.25 110.857 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 20' ' ' ASP . 8.1 p30 -76.62 -40.94 47.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.864 -1.147 . . . . 0.26000000000000001 109.425 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . -47.14 -26.07 1.04 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.446 -0.946 . . . . 0.35999999999999999 108.446 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' HA ' HD12 ' A' ' 28' ' ' LEU . 85.4 mm-40 -86.66 -32.53 20.48 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.495 -0.928 . . . . 1.4399999999999999 108.495 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.618 ' SD ' HG21 ' A' ' 58' ' ' VAL . 2.8 mtt -72.71 -24.62 61.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.525 -0.735 . . . . 2.1499999999999999 109.032 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 28' ' ' LEU . 33.7 mmm-85 -79.99 -13.29 59.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 3.2599999999999998 109.657 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.536 HD12 ' HA ' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -44.72 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 1.51 109.598 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.95 -21.85 46.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.641 -1.384 . . . . 1.4099999999999999 109.641 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.42 59.56 0.88 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.498 -1.441 . . . . 1.55 109.498 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.2 mt -81.42 -9.72 59.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.16 . . . . 1.76 109.541 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 38' ' ' PRO . 31.9 p -140.09 131.76 27.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.4199999999999999 109.607 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.54 64.23 1.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 4.8499999999999996 109.231 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.992 ' HB1' ' HD2' ' A' ' 35' ' ' PRO . . . -132.34 177.33 2.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 3.52 109.276 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.992 ' HD2' ' HB1' ' A' ' 34' ' ' ALA . 35.0 Cg_endo -77.6 56.11 5.45 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.547 2.165 . . . . 4.25 110.307 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.23 -161.06 33.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.399 -1.48 . . . . 2.3100000000000001 109.399 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.468 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -122.28 172.6 5.0 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 2.4399999999999999 109.376 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 34.0 Cg_endo -77.65 -73.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.666 2.244 . . . . 0.65000000000000002 110.499 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.913 HG22 ' CD1' ' A' ' 55' ' ' PHE . 56.7 t -50.23 148.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.038 -1.039 . . . . 0.35999999999999999 108.766 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -126.86 -38.48 2.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.01 . . . . 1.78 111.226 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . . . -136.77 104.69 5.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.75 -1.219 . . . . 0.57999999999999996 110.692 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG22 ' HA ' ' A' ' 53' ' ' LEU . 40.8 t -119.83 72.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 1.01 109.47 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.444 ' HG3' ' OE1' ' A' ' 15' ' ' GLU . 16.3 mt-30 -71.57 157.23 38.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 2.29 109.557 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 45' ' ' ASN . 5.3 mp -105.73 168.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 109.178 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.612 ' CB ' ' CE2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -129.07 144.35 51.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 2.79 109.755 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.609 ' HG3' ' CE1' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -88.47 -149.82 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 4.7300000000000004 109.434 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 46' ' ' GLN . 76.8 m-20 61.6 -125.64 0.82 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 5.0599999999999996 109.266 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -52.32 -19.72 2.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.802 -1.186 . . . . 6.1200000000000001 109.508 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 48' ' ' LYS . 11.6 m-20 80.62 97.33 0.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.462 -0.774 . . . . 3.6800000000000002 109.575 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CE2' ' CB ' ' A' ' 45' ' ' ASN . 1.2 p90 -153.37 168.89 24.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.805 -0.813 . . . . 1.6399999999999999 108.805 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.25 167.77 21.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.975 -1.078 . . . . 0.28000000000000003 110.782 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.81 ' O ' HG13 ' A' ' 42' ' ' VAL . 5.9 m-85 -134.36 149.69 50.85 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.201 -1.037 . . . . 1.3200000000000001 108.201 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.83 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -123.21 116.23 23.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.944 -1.097 . . . . 0.73999999999999999 108.764 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.809 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 62.5 tt0 -95.98 121.97 38.31 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.504 -0.747 . . . . 2.3900000000000001 110.34 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.913 ' CD1' HG22 ' A' ' 39' ' ' VAL . 2.0 m-85 -107.9 121.19 44.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.292 -0.88 . . . . 1.24 109.254 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -1.0 57.88 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.387 -0.821 . . . . 3.71 109.426 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 58' ' ' VAL . 0.9 OUTLIER -161.0 -35.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 1.6899999999999999 110.554 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.739 HG12 ' CB ' ' A' ' 55' ' ' PHE . 0.3 OUTLIER -42.95 124.09 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.099 -1.001 . . . . 1.6899999999999999 109.875 -179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.51 43.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 3.0499999999999998 108.743 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 63' ' ' GLN . 5.1 tt0 -123.37 1.13 9.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.48 -0.763 . . . . 3.6000000000000001 109.502 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 60' ' ' GLU . 2.4 t -43.16 -25.95 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.97999999999999998 109.911 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.534 ' CG2' ' HG3' ' A' ' 63' ' ' GLN . 4.5 t -86.65 -43.52 12.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.114 -0.991 . . . . 0.71999999999999997 110.101 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 21.8 mt-30 -86.28 -16.42 37.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 1.49 109.765 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.87 ' HB3' ' CD1' ' A' ' 4' ' ' LEU . . . -48.96 -30.86 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.03 -1.044 . . . . 0.52000000000000002 108.701 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 78.2 mtp -57.41 -19.39 23.19 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.23 -1.026 . . . . 2.1299999999999999 108.23 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.15 -32.37 66.31 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.636 -0.665 . . . . 0.33000000000000002 109.246 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' O ' ' C ' ' A' ' 68' ' ' ASP . 31.4 m-85 -81.0 4.01 21.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.073 -1.017 . . . . 1.3200000000000001 108.873 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 79' ' ' ILE . 13.5 t0 -39.82 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.557 -0.714 . . . . 1.1200000000000001 109.453 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 77' ' ' LEU . . . 102.86 -73.15 0.29 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.89 -1.684 . . . . 0.19 108.89 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.865 HG22 HD12 ' A' ' 77' ' ' LEU . 7.2 tt 39.18 -132.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.826 -0.808 . . . . 0.26000000000000001 109.021 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.697 ' N ' HG23 ' A' ' 70' ' ' ILE . 12.1 mm -152.29 115.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.015 -1.678 . . . . 0.29999999999999999 109.662 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.897 ' HB3' HD21 ' A' ' 77' ' ' LEU . 42.3 t80 -122.93 129.66 51.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.336 -0.853 . . . . 1.25 109.588 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 45.35 39.13 4.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 1.29 109.468 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.33 60.79 8.3 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.439 -1.464 . . . . 0.42999999999999999 109.439 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -168.84 127.89 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -1.173 . . . . 1.6100000000000001 109.562 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.482 ' O ' HD23 ' A' ' 77' ' ' LEU . 4.4 t -51.16 160.99 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.32000000000000001 109.747 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.897 HD21 ' HB3' ' A' ' 72' ' ' PHE . 14.9 mt -129.86 -171.83 2.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.25 109.482 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -160.14 95.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.96 . . . . 1.8799999999999999 109.561 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.587 HD11 ' HE2' ' A' ' 22' ' ' PHE . 1.3 mt -79.74 149.54 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.137 -0.977 . . . . 0.81000000000000005 109.56 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.558 ' HB2' ' CD1' ' A' ' 5' ' ' TYR . 0.6 OUTLIER -130.02 -177.6 4.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 2.4300000000000002 109.682 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -117.51 95.29 47.35 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 4.0700000000000003 109.34 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 3' ' ' ARG . 35.4 Cg_endo -77.23 49.91 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.619 2.213 . . . . 1.5900000000000001 110.52 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 84' ' ' ASP . 7.1 t60 -129.86 -32.91 1.84 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.918 . . . . 5.0599999999999996 109.665 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER 40.66 56.0 2.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.463 -0.773 . . . . 5.5499999999999998 109.708 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -78.55 159.63 28.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -0.869 . . . . 8.4299999999999997 109.576 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' OE1' ' CE2' ' A' ' 85' ' ' TYR . 93.0 mt-30 45.49 91.48 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 6.6500000000000004 109.511 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 35.3 Cg_endo -77.67 94.28 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.825 2.35 . . . . 5.0899999999999999 110.439 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -42.35 102.57 0.28 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 7.3899999999999997 109.656 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 87' ' ' PRO . 36.1 Cg_endo -78.47 171.49 16.75 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.496 2.131 . . . . 7.6100000000000003 110.382 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 CA-C-O 118.008 -1.44 . . . . 9.3000000000000007 109.556 179.978 . . . . . . . . 0 0 . 1 stop_ save_